Search
for
Sort by
Research 781–810 of 1000+
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Serum granulysin as a possible key marker of the activity of alopecia areata
- Efficacy of Korean Red Ginseng in the Treatment of Alopecia Areata
- The Genetic Architecture of Alopecia Areata
- Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
- Hair-growth promoting effect and anti-inflammatory mechanism of Ginkgo biloba polysaccharides
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Periplaneta americana extract (L.) promotes hair regrowth in Alopecia areata mice by reducing inflammation and modulating skin microbiota
- Investigation of Vaspin and Visfatin -4689G/T Gene Polymorphisms in Alopecia Areata Patients
- JAK Inhibitors for Treatment of Alopecia Areata
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Excimer Light versus Combination of Tacrolimus and Excimer Light in the Treatment of Alopecia Areata
- 0150 Single-cell and spatial transcriptome profiling reveals innate-adaptive crosstalk in alopecia areata
- Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relationship with alopecia areata severity
- Alopecia Areata: Features and Psychological Profiles (South American Perspectives)
- LB1040 Machine learning-based predictive model with routine blood work identifies moderate-severe alopecia areata
- [ADAPTIVE REGULATORY MECHANISMS OF ALOPECIA AREATA].
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- The immunopathogenesis of Alopecia Areata
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- 0036 IL-27 generates immunosuppressive CD4 T cells and and prevents the development of alopecia areata
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- 058 The pattern of Fas and Fas ligand expression in alopecia areata
- 014 Tyrosine Kinase 2 Inhibition Ameliorates the Phenotype of Lesional Alopecia Areata Scalp Skin Ex Vivo, and Reverses the Induction of Human Alopecia Areata in a Humanized Mouse Model